• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过控制其启动子中特定的 GQ 形成,合理设计的 DNA 疗法可以调节人类 TH 表达。

Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter.

机构信息

Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA; Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA.

Department of Chemistry and Biochemistry, Kent State University, Kent, OH 44242, USA; Department of Chemical Sciences, Faculty of Applied Sciences, South Eastern University of Sri Lanka, Oluvil, Sri Lanka.

出版信息

Mol Ther. 2022 Feb 2;30(2):831-844. doi: 10.1016/j.ymthe.2021.05.013. Epub 2021 May 14.

DOI:10.1016/j.ymthe.2021.05.013
PMID:33992806
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8822133/
Abstract

Tyrosine hydroxylase (TH) catalyzes the rate-limiting step in the catecholamine (CA) biosynthesis pathway, making TH a molecular target for controlling CA production, specifically dopamine. Dysregulation of dopamine is correlated with neurological diseases such as Parkinson's disease (PD) and post-traumatic stress disorder (PTSD), among others. Previously, we showed that a 49-nucleotide guanine (G)-rich sequence within the human TH promoter adopts two different sets of G-quadruplex (GQ) structures (5'GQ and 3'GQ), where the 5'GQ uses G-stretches I, II, IV, and VI in TH49, which enhances TH transcription, while the 3'GQ utilizes G-stretches II, IV, VI, and VII, which represses transcription. Herein, we demonstrated targeted switching of these GQs to their active state using rationally designed DNA GQ Clips (5'GQ and 3'GQ Clips) to modulate endogenous TH gene expression and dopamine production. As a translational approach, we synthesized a targeted nanoparticle delivery system to effectively deliver the 5'GQ Clip in vivo. We believe this strategy could potentially be an improved approach for controlling dopamine production in a multitude of neurological disorders, including PD.

摘要

酪氨酸羟化酶(TH)催化儿茶酚胺(CA)生物合成途径中的限速步骤,使 TH 成为控制 CA 产生的分子靶点,特别是多巴胺。多巴胺的失调与帕金森病(PD)和创伤后应激障碍(PTSD)等神经疾病有关。先前,我们表明人类 TH 启动子内的 49 个核苷酸鸟嘌呤(G)富含序列采用两种不同的 G-四链体(GQ)结构(5'GQ 和 3'GQ),其中 5'GQ 使用 TH49 中的 G 链 I、II、IV 和 VI,增强 TH 转录,而 3'GQ 利用 G 链 II、IV、VI 和 VII,抑制转录。在此,我们使用合理设计的 DNA GQ 夹(5'GQ 和 3'GQ 夹)证明了这些 GQ 向其活性状态的靶向转换,以调节内源性 TH 基因表达和多巴胺产生。作为一种转化方法,我们合成了一种靶向纳米颗粒递送系统,以有效递送至体内的 5'GQ 夹。我们相信,这种策略可能是控制包括 PD 在内的多种神经疾病中多巴胺产生的一种改进方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/8822133/54f9608c63c4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/8822133/54f9608c63c4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4431/8822133/54f9608c63c4/fx1.jpg

相似文献

1
Rationally designed DNA therapeutics can modulate human TH expression by controlling specific GQ formation in its promoter.通过控制其启动子中特定的 GQ 形成,合理设计的 DNA 疗法可以调节人类 TH 表达。
Mol Ther. 2022 Feb 2;30(2):831-844. doi: 10.1016/j.ymthe.2021.05.013. Epub 2021 May 14.
2
G-Quadruplex-Enabling Sequence within the Human Tyrosine Hydroxylase Promoter Differentially Regulates Transcription.人类酪氨酸羟化酶启动子内的G-四链体形成序列对转录具有差异调控作用。
Biochemistry. 2015 Sep 15;54(36):5533-45. doi: 10.1021/acs.biochem.5b00209. Epub 2015 Aug 28.
3
Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.酪氨酸羟化酶(TH)、其辅因子四氢生物蝶呤(BH4)、其他儿茶酚胺相关酶及其人类基因与帕金森病(PD)的药物和基因治疗:历史概述与未来展望
J Neural Transm (Vienna). 2016 Nov;123(11):1255-1278. doi: 10.1007/s00702-016-1596-4. Epub 2016 Aug 4.
4
Overview of tyrosine hydroxylase in Parkinson's disease.帕金森病中酪氨酸羟化酶概述。
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):350-8. doi: 10.2174/187152712800792901.
5
Current status of tyrosine hydroxylase in management of Parkinson's disease.酪氨酸羟化酶在帕金森病治疗中的现状。
CNS Neurol Disord Drug Targets. 2012 Jun 1;11(4):450-5. doi: 10.2174/187152712800792910.
6
Human tyrosine hydroxylase in Parkinson's disease and in related disorders.帕金森病及相关疾病中的人类酪氨酸羟化酶。
J Neural Transm (Vienna). 2019 Apr;126(4):397-409. doi: 10.1007/s00702-018-1903-3. Epub 2018 Jul 11.
7
Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.用表达酪氨酸羟化酶、芳香族L-氨基酸脱羧酶和GTP环水解酶I的腺相关病毒载体进行三重转导用于帕金森病的基因治疗。
Hum Gene Ther. 2000 Jul 20;11(11):1509-19. doi: 10.1089/10430340050083243.
8
The role of tyrosine hydroxylase-dopamine pathway in Parkinson's disease pathogenesis.酪氨酸羟化酶-多巴胺通路在帕金森病发病机制中的作用。
Cell Mol Life Sci. 2022 Nov 21;79(12):599. doi: 10.1007/s00018-022-04574-x.
9
Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholamines.酪氨酸羟化酶 N 端在儿茶酚胺生物合成中的作用。
J Neural Transm (Vienna). 2009 Nov;116(11):1355-62. doi: 10.1007/s00702-009-0227-8. Epub 2009 Apr 25.
10
Identification and characterization of potential cis-regulatory elements governing transcriptional activation of the rat tyrosine hydroxylase gene.调控大鼠酪氨酸羟化酶基因转录激活的潜在顺式调控元件的鉴定与表征
J Neurochem. 1998 Oct;71(4):1358-68. doi: 10.1046/j.1471-4159.1998.71041358.x.

引用本文的文献

1
Stalling of Transcription by Putative G-quadruplex Sequences and CRISPR-dCas9.假定的G-四链体序列和CRISPR-dCas9导致的转录停滞
bioRxiv. 2024 Mar 17:2024.03.17.585391. doi: 10.1101/2024.03.17.585391.
2
Recognition Interface of the Thrombin Binding Aptamer Requires Antiparallel Topology of the Quadruplex Core.凝血酶结合适体的识别界面需要四链体核心的反平行拓扑结构。
Biomolecules. 2021 Sep 9;11(9):1332. doi: 10.3390/biom11091332.

本文引用的文献

1
Selective targeting of mutually exclusive DNA G-quadruplexes: HIV-1 LTR as paradigmatic model.选择性靶向相互排斥的 DNA G-四链体:HIV-1 LTR 作为典范模型。
Nucleic Acids Res. 2020 May 21;48(9):4627-4642. doi: 10.1093/nar/gkaa186.
2
Insight into Cellular Uptake and Intracellular Trafficking of Nanoparticles.纳米颗粒的细胞摄取与细胞内运输洞察
Nanoscale Res Lett. 2018 Oct 25;13(1):339. doi: 10.1186/s11671-018-2728-6.
3
Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells.五部分五聚体纳米复合物显示阿霉素在CD44 +癌细胞中的疗效得到改善。
ACS Omega. 2017 Nov 30;2(11):7702-7713. doi: 10.1021/acsomega.7b01168. Epub 2017 Nov 9.
4
Modular cell-internalizing aptamer nanostructure enables targeted delivery of large functional RNAs in cancer cell lines.模块化细胞内化适体纳米结构可实现大功能 RNA 在癌细胞系中的靶向递送。
Nat Commun. 2018 Jun 11;9(1):2283. doi: 10.1038/s41467-018-04691-x.
5
Targeting of G-Quadruplex Harboring Pre-miRNA 92b by LNA Rescues PTEN Expression in NSCL Cancer Cells.靶向含有 miRNA 92b 的 G-四链体通过 LNA 恢复 NSCLC 细胞中的 PTEN 表达。
ACS Chem Biol. 2018 Apr 20;13(4):909-914. doi: 10.1021/acschembio.7b00749. Epub 2018 Mar 19.
6
Polyethylenimine Nanoparticle-Mediated siRNA Delivery to Reduce α-Synuclein Expression in a Model of Parkinson's Disease.聚乙烯亚胺纳米颗粒介导的小干扰RNA递送以降低帕金森病模型中α-突触核蛋白的表达
Mol Ther Nucleic Acids. 2017 Dec 15;9:57-68. doi: 10.1016/j.omtn.2017.08.013. Epub 2017 Aug 30.
7
G-quadruplex-binding small molecules ameliorate FTD/ALS pathology and .G-四链体结合小分子改善 FTD/ALS 病理学和 。
EMBO Mol Med. 2018 Jan;10(1):22-31. doi: 10.15252/emmm.201707850.
8
Advances in the delivery of RNA therapeutics: from concept to clinical reality.RNA疗法的递送进展:从概念到临床实践
Genome Med. 2017 Jun 27;9(1):60. doi: 10.1186/s13073-017-0450-0.
9
Overcoming cellular barriers for RNA therapeutics.克服 RNA 治疗药物的细胞屏障。
Nat Biotechnol. 2017 Mar;35(3):222-229. doi: 10.1038/nbt.3802. Epub 2017 Feb 27.
10
Metal Cations in G-Quadruplex Folding and Stability.G-四链体折叠与稳定性中的金属阳离子
Front Chem. 2016 Sep 9;4:38. doi: 10.3389/fchem.2016.00038. eCollection 2016.